Non-surgical treatment of thyroid nodules is possible through minimally invasive, image-guided procedures. These techniques provide alternatives to surgery for selected benign and malignant nodules.
Radiofrequency ablation, laser ablation, and ethanol injection are effective in shrinking nodules and relieving compressive symptoms. They preserve thyroid function and avoid scarring.
Compared to surgical removal, these procedures carry lower complication risks, faster recovery, and outpatient applicability. They are particularly beneficial for patients unfit for surgery.
Indications include symptomatic benign nodules, cosmetic concerns, and selected microcarcinomas. Non-surgical methods ensure safe, effective, and organ-preserving management.
Don’t Be Intimidated by Large Nodules Anymore
Prof. Dr. Özgür Kılıçkesmez states that both RFA and MWA can be safely applied to benign thyroid nodules that have reached significant sizes, cause compressive symptoms (e.g., difficulty swallowing, discomfort in the neck), or create cosmetic issues:
“These treatments significantly reduce nodule volume and provide comfort to patients without surgical scars, general anesthesia, or a long recovery process. Particularly in autonomously functioning (hyperthyroidism‑causing) thyroid nodules, RFA and MWA yield effective results in normalizing hormone levels.”
Effectiveness and Safety: What Do the Data Say?
Volume Reduction Ratio (VRR): Meta‑analyses show that MWA achieves an 83.6% volume reduction at 12 months, while RFA offers an 81.6% reduction.
Improvement in Symptoms and Appearance: After the procedure, patients’ symptom scores decrease from 4 to 1.5, and cosmetic scores improve from 3 to 1. This indicates a significant increase in both quality of life and satisfaction with appearance.
Complication Rates: Both methods are generally considered safe. Some studies report complication rates of 19.9% for MWA and 16.4% for RFA, although most complications are minor and temporary.
Success Rate: At six months post‑treatment, success rates are reported as 99% for MWA and 97% for RFA.
Procedure Time: On average, MWA is 1.56 minutes shorter than RFA, which enhances patient comfort during the procedure.
Painless and Brief Procedure
RFA and MWA procedures are usually performed under local anesthesia. Although the duration varies depending on the number and size of nodules, many patients can be discharged one hour after the procedure. Prof. Dr. Kılıçkesmez emphasizes that aside from mild neck pain or temporary discomfort, the likelihood of serious side effects is very low:
“Thanks to the comfort provided by these non‑surgical methods, patients do not experience large incisions in the neck or long hospital stays. They can almost immediately resume their daily activities.”
Successful Results in AFTN Patients
Autonomously functioning thyroid nodules (AFTN) can cause hyperthyroidism by secreting excess hormones. Thermal ablation methods effectively reduce the volume of these nodules and regulate thyroid hormone levels. Research shows that RFA and MWA significantly improve therapeutic outcomes in this patient group as well.
What Do Patients Say?
Studies report that patients who have undergone RFA and MWA have very high satisfaction levels in terms of quality and comfort. Symptom relief and elimination of cosmetic concerns help patients quickly adapt to social life.
Physician Supervision and Accurate Diagnosis Are Crucial
Finally, Prof. Dr. Özgür Kılıçkesmez emphasizes that not all thyroid nodules are the same and that treatment must be planned by a specialist physician:
“The most appropriate treatment should be chosen based on factors such as the nodule’s structure, size, location, and the patient’s overall health. Interventional radiology offers a safe and effective alternative at this point. Learning about non‑surgical ablation methods before considering surgery can provide a great advantage for patients.”
Prof. Dr. Özgür Kılıçkesmez is one of Türkiye’s leading interventional radiology and neuroradiology specialists, focusing on minimally invasive endovascular treatments. His primary areas of expertise include aneurysm and stroke treatments, embolization procedures, non-surgical treatments of thyroid and parathyroid diseases, interventional oncology, and peripheral vascular interventions. He currently serves as the Head of the Interventional Radiology and Neuroradiology Department at Istanbul Memorial Göztepe Hospital.
Graduating from Istanbul University Cerrahpaşa Faculty of Medicine in 1997, Prof. Dr. Kılıçkesmez received advanced training in interventional radiology and oncology as a Clinical Fellow at London Guy’s & St Thomas’ and King’s College Hospital between 2012 and 2013. He earned the title of Professor in 2020 and, in the same year, became the Founding Interventional Radiologist at SBÜ Çam and Sakura City Hospital. He also holds the EBIR (European Board of Interventional Radiology) certification.
Prof. Dr. Kılıçkesmez has 94 international and 40 national publications and over 2500 citations. He serves as a reviewer for prestigious journals such as the American Journal of Roentgenology (AJR) and Diagnostic & Interventional Radiology. With his clinical and academic expertise, he is a nationally and internationally recognized authority in stroke treatment, brain aneurysm, embolization, tumor ablation, and minimally invasive treatments of thyroid/parathyroid diseases.
Vaka Örnekleri